Drug Search Results
More Filters [+]

Zabofloxacin

Alternative Names: zabofloxacin
Latest Update: 2023-10-12
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Gram+ Bacteria Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Dong Wha
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Zabofloxacin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Chronic Obstructive Pulmonary Disease

Phase 2: Pneumonia

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Bacteriocide

P1

Completed

Healthy Volunteers

2014-08-01

DW224-III-3

P3

Completed

Chronic Obstructive Pulmonary Disease

2014-01-01

PB-101-200

P2

Terminated

Pneumonia

2012-04-01

Recent News Events